
浏览全部资源
扫码关注微信
1. 山东中医药高等专科学校
2. 烟台市疾病预防控制中心
纸质出版日期:2021,
扫 描 看 全 文
[1]梁娟,崔伟红,朱董楠.不同剂次水痘疫苗在学校和幼儿园水痘聚集疫情中的保护效力分析[J].保健医学研究与实践,2021,18(02):35-38.
Liang Juan, Cui Weihong, Zhu Dongnan. Analysis of the efficacy of different doses of varicella vaccine in varicella aggregation outbreaks in schools and kindergartens[J]. Health Medicine Research and Practice, 2021,18(2):35-38.
[1]梁娟,崔伟红,朱董楠.不同剂次水痘疫苗在学校和幼儿园水痘聚集疫情中的保护效力分析[J].保健医学研究与实践,2021,18(02):35-38. DOI:
Liang Juan, Cui Weihong, Zhu Dongnan. Analysis of the efficacy of different doses of varicella vaccine in varicella aggregation outbreaks in schools and kindergartens[J]. Health Medicine Research and Practice, 2021,18(2):35-38. DOI:
目的评价不同剂次水痘疫苗(Var V)在学校和幼儿园水痘聚集疫情中的疫苗保护效力(VE)。方法选择烟台市2015—2016年发生水痘聚集疫情的10所学校/幼儿园的21个班级
共816名学生(剔除了26名2015年以前患过水痘的学生)作为研究对象
采用回顾性队列研究方法评价不同剂次Var V的VE。结果研究对象中
接种2剂次组、1剂次组和未接种组研究对象的水痘罹患率分别为2.11%、11.53%、23.26%
差异有统计学意义(P<0.05)。2剂次Var V的VE为90.93%
1剂次Var V的VE为50.43%。接种1剂次Var V的研究对象中
接种年限<3年组VE为85.68%
接种年限≥3年组VE仅为46.82%
差异无统计学意义(P>0.05)。接种2剂次Var V的研究对象中
接种年限<3年组VE为92.30%
接种年限≥3年组VE为89.68%
差异并无统计学意义(P>0.05)。接种1剂次Var V的研究对象中
接种起始年龄为1~<3岁组VE为48.07%
接种起始年龄≥3岁组VE为57.52%
差异并无统计学意义(P>0.05)。接种2剂次Var V的研究对象中
接种起始年龄为1~<3岁组VE为90.63%
接种起始年龄≥3岁组VE为100.00%
差异亦无统计学意义(P>0.05)。不同接种剂次研究对象中病例类型的分布差异具有统计学意义(P<0.05)
接种2剂次Var V的研究对象出现了3例轻症病例
占比60.00%
高于未接种和1剂次Var V接种的研究对象。未接种的研究对象中出现的中型及重型病例分别有49例(81.67%)及2例(3.33%)
高于1剂次Var V接种和2剂次Var V接种的研究对象。结论接种2剂次疫苗免疫持久性更好
在控制水痘聚集疫情方面更有效。建议逐步在儿童中实施2剂次Var V接种免疫策略以有效预防水痘的发生。
Objective To evaluate the vaccine efficacy(VE) of different doses of varicella vaccine(Var V) in vari-cella aggregated outbreaks in schools and kindergartens. Methods A total of 816 students(26 students who had varicella before 2015 were excluded) from 21 classes in 10 schools/kindergartens in Yantai where varicella aggre-gation outbreaks occurred in 2015—2016 were selected as study subjects
and a retrospective cohort study was used to evaluate the VE of Var Vof different doses. Results Among the study subjects
the prevalence of vari-cella was 2.11%
11.53% and 23.26% in the 2-dose
1-dose and non-vaccinated groups
respectively
with sta-tistically significant differences(P<0.05). The VE of 2-dose Var V was 90.93%
and that of 1-dose Var V was 50.43%. Among the subjects immunized with 1-dose Var V
the VE of the group with <3 years of vaccination was 85.68%
and that of the group with ≥3 years of vaccination was only 46.82%
with no statistically signifi-cant difference(P>0.05). Among the subjects immunized with 2-dose Var V
the VE of the group with <3 years of vaccination was 92.30%
and that of the group with ≥3 years of vaccination was 89.68%
with no sta-tistically significant difference(P>0.05). Among the study subjects immunized with 1 dose of Var V
the VE was 48.07% in the group with an age at vaccination onset of 1 ~<3 years and 57.52% in the group with an age at vaccination onset of ≥3 years
and the difference was not statistically significant(P>0.05). Among the stud-y subjects immunized with 2 doses of VarV
the VE was 90.63% in the group with an age at vaccination onset of 1~<3 years and 100.00% in the group with an age at vaccination onset of ≥3 years
and the difference was not statistically significant(P>0.05).The difference in the distribution of case types among the study subjects with different vaccination doses was statistically significant(P<0.05)
with 3 mild cases(60.00%) occurring in the study subjects with 2 doses of Var Vimmunization
which was higher than in the study subjects with no vaccina-tion and 1 dose of Var Vimmunization. There were 49(81.67%) and 2(3.33%) medium and heavy cases in the unvaccinated study subjects
more than those in the 1-dose Var Vimmunized-and 2-dose Var Vimmunized-study subjects
respectively. Conclusion Immunization with 2-doze vaccine has better durability and is more effective in controlling varicella aggregation outbreaks. A gradual implementation of a 2-dose Var Vimmunization strategy in children is recommended for effective prevention of varicella.
水痘疫苗学校和幼儿园疫苗效力
Varicella vaccineSchools and kindergartensVaccine efficacy
0
浏览量
17
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621